Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 August 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Mesenchymal stromal cells for fistula treatment of Crohn’s disease

The latest issue of the Digestive Diseases & Sciences examines the efficacy of mesenchymal stromal cells for fistula treatment of Crohn’s disease.

News image

The introduction of mesenchymal stromal cells has changed the management of Crohn’s fistula, while it remains controversial. 

Dr Lin and colleagues provided an overview of efficacy and optimum state of mesenchymal stromal cells treatment on Crohn’s fistula.

Studies reporting mesenchymal stromal cells treatment on Crohn’s fistula were searched and included. 

A fixed-effects model was used to assess the efficacy of mesenchymal stromal cells, and outcomes of healing and recurrence were used to evaluate the best states of mesenchymal stromal cells intervention.

The team enrolled 14 articles. 

A moderate dose mesenchymal stromal cells had a higher healing rate
Digestive Diseases & Sciences
The research team showed mesenchymal stromal cells had a significant efficacy compared to other treatments. 

Notably, after mesenchymal stromal cells treatment, the group of Crohn’s disease activity index (CDAI) baseline >150 group had a higher healing rate, and a clinical response compared to CDAI baseline of <150. 

The research team found that the duration time of Crohn’s disease, and fistulas had a negative correlation with healing rate accompanied by mesenchymal stromal cells therapy. 

Then, a moderate dose mesenchymal stromal cells had a higher healing rate, and lower recurrence rate compared to other dosages. 

Moreover, the team noted that adipose-derived mesenchymal stromal cells therapy had an advantage over bone marrow-derived mesenchymal stromal cells in terms of low relative risk.

Dr Lin's team comments, "The evidence supported the effect of mesenchymal stromal cells at a more appropriate time of Crohn’s fistula."

"CDAI baseline has been a candidate for evaluating effectiveness of mesenchymal stromal cells application on Crohn’s fistula."

Dig Dis Sci 2017: 62(4): 851–860
20 March 2017

Go to top of page Email this page Email this page to a colleague

 24 August 2017 
Bariatric surgery liver biopsies
 24 August 2017 
Guidelines for the management of inherited polyposis syndromes
 24 August 2017 
Steatosis in bariatric surgery candidates with NAFLD
 23 August 2017 
Outcomes of bowel cancer screening with a fecal immunochemical test
 23 August 2017 
Arterial stiffness in NAFLD
 23 August 2017 
Colectomy rates in patients with ulcerative colitis
 22 August 2017 
Improving the diagnostic accuracy of severe liver fibrosis in NAFLD
 22 August 2017 
New therapies to manage Hep B
 22 August 2017 
Survival in patients with Lynch syndrome
 21 August 2017 
Improving medication adherence in IBD
 21 August 2017 
Treatments for chronic idiopathic constipation
 21 August 2017 
Ethnic disparities for chronic Hep C survival
 18 August 2017 
Proteomic analysis of IBD
 18 August 2017 
Pediatric intestinal failure
 18 August 2017 
Anti-TNF treatment and bowel resection in Crohn's
 17 August 2017 
Outcomes of ulcerative colitis patients undergoing pouch surgery
 17 August 2017 
Mortality in patients with asymptomatic pancreatic cystic neoplasms
 17 August 2017 
Survival after primary tumor resection in advanced colorectal cancer
 16 August 2017 
Assessment of seronegative villous atrophy
 16 August 2017 
Appendectomy and colectomy risk in ulcerative colitis
 16 August 2017 
Gluten sensitivity and celiac disease
 15 August 2017 
Infliximab and treatment failure during maintenance
 15 August 2017 
Genetic in idiopathic pancreatitis
 15 August 2017 
Genetic factors and tobacco in IBD
 14 August 2017 
Per oral endoscopic myotomy
 14 August 2017 
Early colonoscopy and symptomatic colorectal cancer
 14 August 2017 
Ethnic disparities and Hep C survival
 11 August 2017 
Ledipasvir and sofosbuvir in treatment-naïve Hep C
 11 August 2017 
EBV DNA to screen for nasopharyngeal cancer
 11 August 2017 
Direct acting antivirals and mixed cryoglobulinemia
 10 August 2017 
Routine preoperative laboratory tests for elective surgery
 10 August 2017 

Whole-genome sequencing in primary care

 10 August 2017 
Mortality in cirrhosis
 09 August 2017 
Anticoagulants in cirrhosis
 09 August 2017 
Low birthweight and pediatric NAFLD
 09 August 2017 
IBS with extraintestinal somatic and psychological symptoms
 08 August 2017 
Prior Barrett’s diagnosis and esophageal cancer survival
 08 August 2017 
Imaging index for fistulizing Crohn's
 08 August 2017 
Statin use after colon cancer
 07 August 2017 
Contraindications of biologic therapies in IBD
 07 August 2017 
Predicting clinical outcome in colorectal cancer
 07 August 2017 
Future burden of esophageal cancer
 04 August 2017 
Internet decision-making resources for ulcerative colitis surgery
 04 August 2017 
Distal findings and proximal colorectal neoplasia
 04 August 2017 
CT colonography vs flexible sigmoidoscopy
 03 August 2017 
Bloating and abdominal distension
 03 August 2017 
Predictors of colectomy in ulcerative colitis
 03 August 2017 
Treatment for sensitized transplant patients
 02 August 2017 
Preventing reactivation of Hep B
 02 August 2017 
Improving medication adherence in IBD
 02 August 2017 
Multiply recurrent C. difficile in the USA
 01 August 2017 
Coping with IBD
 01 August 2017 
Hepatocellular carcinoma in autoimmune hepatitis
 01 August 2017 
Anti-TNF treatment in Crohn's disease
 31 July 2017 
Global HCV incidence and mortality elimination targets
 31 July 2017 
Diagnosing GERD
 31 July 2017 
Diagnostic accuracy of severe liver fibrosis in patients with NAFLD
 28 July 2017 
Low FODMAP diet in IBS
 28 July 2017 
IBD patient–centered medical home
 28 July 2017 
Excluding NAFLD in the general population

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us